ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Motivational Enhancement for Spanish Speaking Individuals - 1

This study is currently recruiting patients.

Sponsored by: National Institute on Drug Abuse (NIDA)
Yale University
Information provided by: National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this study is to compare a three-session Spanish version of Motivational Enhancement Therapy (MET) to standard treatment to see how well MET engages and retains Spanish-speaking clients in outpatient substance abuse treatment.

Condition Treatment or Intervention Phase
Substance-Related Disorders
 Behavior: Behavior Therapy
Phase III

MedlinePlus related topics:  Drug Abuse;   Prescription Drug Abuse

Study Type: Interventional
Study Design: Treatment, Uncontrolled

Official Title: Motivational Enhancement for Spanish Speaking Individuals

Further Study Details: 

Expected Total Enrollment:  480

Study start: September 2002

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

All subjects included unless medical/psychiatrically unstable


Location and Contact Information

Julie Matthews      (860)704-6174    jmatthews@abhct.com

Colorado
      Island Grove RTC, Greeley,  Colorado,  80631,  United States; Recruiting
Julie Matthews  860-704-6174    jmatthews@abhct.com 

Florida
      Miami Behavioral Health, Miami,  Florida,  33161,  United States; Recruiting
Julie Matthews  860-704-6174    jmatthews@abhct.com 

New Mexico
      Counseling & Psychotherapy Institute, Albuquerque,  New Mexico,  87194,  United States; Recruiting
Julie Matthews  860-704-6174    jmatthews@abhct.com 

      The Life Link, Santa Fe,  New Mexico,  87505,  United States; Recruiting
Julie Matthews  860-704-6174    jmatthews@abhct.com 

New York
      Narco Freedom (Bridge Plaza), Long Island City,  New York,  11101,  United States; Recruiting
Julie Matthews  860-704-6174    jmatthews@abhct.com 

Oregon
      Changepoint, Inc., Portland,  Oregon,  97402,  United States; Recruiting
Julie Matthews  860-704-6174    jmatthews@abhct.com 

      Changepoint - Cedar Hills Blvd, Portland,  Oregon,  97292,  United States; Not yet recruiting
Julie Matthews  860-704-6174    jmatthews@abhct.com 

Study chairs or principal investigators

Kathleen Carroll, Ph.D.,  Principal Investigator,  Yale University   

More Information

Study ID Numbers:  NIDA-CTN-0021-1
Record last reviewed:  October 2004
Record first received:  February 19, 2004
ClinicalTrials.gov Identifier:  NCT00078169
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2004-11-08
line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act